Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 1999

View Archived Issues

Key proteomics patents issued to Oxford GlycoSciences

Licensing opportunity from Peptech: anti-TNF antibodies with a range of therapeutic applications

Banyu reviews new product pipeline

New cysteine protease inhibitors from SB for osteoporosis, arthritis, etc.

Hybridon develops antisense oligonucleotides to thymidylate synthase

Sydnonimine derivatives for cardiovascular disorders presented by Chugai

Taiho synthesizes novel compounds for bone metabolism disorders

Novel condensed pyridazines claimed by Takeda for allergic conditions

Peripherally selective kappa-opioid agonists in early development at Warner-Lambert

Excellent clinical results reported for ID Biomedical's rapid MRSA test; February filing announced

Seven-day treatment with AIT-082 leads to memory improvement in elderly volunteers

Scios AD research partnership with Lilly extended

Generic smoking cessation aid receives tentative FDA approval

Medarex receives milestone payment from Centocor related to HuMAb-Mouse technology

GelTex reports success with first- and second-generation cholesterol-lowering compounds

Nankai University team describes new compound with antileukemia activity

New antibiotic isolated and characterized at the Institute of Microbial Chemistry in Tokyo

Antibiotic produced by unidentified fungus shows activity against resistant bacteria

FDA advisory committee reaches positive conclusions regarding Chirocaine

Temodal receives positive recommendation for one indication from FDA advisory committee

First vaccine for Lyme disease now available from SB in the U.S.

PathoGenesis puts development of TB drug on hold

European study establishes long-term efficacy and safety of alprostadil alfadex

Medeva acquires license for scleroderma Rx from Connetics

Priority review status granted for Merck & Co.'s COX-2 inhibitor

PAF antagonist safe but not effective in the treatment of ulcerative colitis

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...